Parenteral Drugs (India) Ltd.

    Parenteral Drugs (India) Ltd.

    NNSE:PDPL
    - -
    INR
    - -
    - -
    2010 Y
    2011 Y
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    TTM
    Revenue per Share
    219.29
    186.54
    124.34
    119.6
    86.46
    84.23
    82.94
    80.1
    75.77
    10.73
    8.06
    4.08
    2.85
    2.85
    Basic EPS, GAAP
    16.11
    1.71
    -20.64
    -41.69
    -15.15
    -22.69
    -39.09
    -39.52
    -37.5
    -49.61
    -38.26
    -40.82
    -25.61
    -25.61
    Free Cash Flow per Basic Share
    -27.57
    -12.16
    -49.67
    -72.94
    -58.36
    -2.44
    -17.45
    44.93
    55.53
    159.99
    37.69
    -0.04
    -0.16
    - -
    Dividend per Share
    2
    0.89
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    127.29
    135.46
    130.32
    88.47
    62.7
    37.47
    33.74
    -11.85
    -45.76
    -149.89
    -188.25
    -229.03
    -276.37
    -276.37
    Tangible Book Value per Share
    76.19
    84.36
    79.22
    37.37
    18.37
    -5.7
    33.74
    -11.85
    -45.76
    -149.89
    -188.25
    -229.03
    -276.37
    -276.37
    Basic Weighted Avg Shares
    19
    26
    26
    26
    30
    30
    30
    30
    30
    30
    30
    30
    30
    30
    Sales/Revenue/Turnover
    4,145
    4,822
    3,216
    3,094
    2,578
    2,511
    2,473
    2,388
    2,259
    320
    240
    122
    85
    85
    Operating Margin (%)
    13.8
    7.84
    -0.01
    -11.9
    -18.65
    -6.77
    -22.85
    -9.82
    -10.02
    -271.2
    -131.48
    -239.15
    -649.25
    -649.25
    Depreciation Expense
    90
    126
    145
    230
    186
    310
    228
    249
    242
    691
    173
    173
    401
    401
    Net Income, GAAP
    304
    44
    -534
    -1,078
    -452
    -677
    -1,165
    -1,178
    -1,118
    -1,479
    -1,141
    -1,217
    -764
    -764
    Effective Tax Rate (%)
    23.37
    45.87
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    7.35
    0.92
    -16.6
    -34.86
    -17.52
    -26.94
    -47.13
    -49.34
    -49.49
    -462.23
    -474.81
    -1,000.31
    -898.77
    -898.77
    Working Capital
    1,939
    1,852
    -528
    304
    340
    51
    -1,541
    -3,058
    -4,935
    -8,102
    -9,382
    -10,756
    -11,337
    -11,337
    LT Debt
    2,558
    3,258
    2,096
    3,663
    4,000
    4,123
    4,358
    3,807
    3,086
    330
    305
    305
    1,072
    1,072
    Total Equity
    3,298
    3,510
    3,497
    2,469
    2,030
    1,278
    1,009
    -172
    -1,362
    -4,468
    -5,612
    -6,828
    -8,239
    -8,239
    Return on Invested Capital (%)
    8.12
    3.19
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    5.77
    0.61
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    9.98
    1.3
    -15.53
    -38.11
    -21.73
    -45.31
    -109.79
    - -
    - -
    - -
    - -
    - -
    - -
    -407.39

    Capital Structure

    INR

    •

    in mil. unless spec.
    Sep'22
    Dec'22
    Mar'22
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    1,073
    - -
    1,072
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    30
    30
    30
    Market Capitalization
    85
    113
    107

    Working Capital

    INR

    •

    in mil. unless spec.
    Sep'22
    Dec'22
    Mar'22
    Total Current Assets
    673
    - -
    671
    Cash, Cash Equivalents & STI
    - -
    - -
    - -
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    6
    - -
    10
    Total Current Liabilities
    12,183
    - -
    12,008
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    INR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    76.72%
    197.9%
    20.67%
    Free Cash Flow
    57.15%
    74.16%
    335.65%
    Net Income, GAAP
    14.08%
    -5.25%
    -37.26%
    Sales/Revenue/Turnover
    -22.37%
    -39.14%
    -30.17%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2020
    87
    73
    72
    7
    240
    2021
    29
    46
    20
    26
    122
    2022
    29
    24
    14
    18
    85

    Quarterly Earnings Per Share

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2020
    -9.29
    -9.5
    -8.77
    - -
    -38.26
    2021
    -10.81
    -11.29
    -10.39
    - -
    -40.82
    2022
    -10.74
    -11.27
    -11.58
    - -
    -25.61

    Quarterly Dividends Per Share

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2020
    - -
    - -
    - -
    - -
    - -
    2021
    - -
    - -
    - -
    - -
    - -
    2022
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business